FDA Approves Insys Therapeutics’ 2nd Cannabis-Based Drug July 6, 2016 AggregatedNews Cannabis Investments 0 Comments On June 21, Todd Hagopian recommended Insys Therapeutics (INSY). Since then, the stock has gained nearly 20%. After a stock runs like this, many investors are tempted to sell. However, in situations like this, I’ve found it valuable to know which side… Read More→